Nexgel, Inc. (NXGL): R&D Expense
$2.0K
Year ended 2025-12-31
$21.0K
Trailing 12 months to 2026-06-30
-82.4%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.0K | -97.4% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $78.0K | -24.3% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $103.0K | -71.9% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $367.0K | n/m | 2024-04-10, From 2022-01-01 |
| 2021-12-31 | $31.0K | n/a | 2023-03-28, From 2021-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Nexgel, Inc. (NXGL) | 2025-12-31 | $2.0K | -97.4% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $435.3K | +43.9% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $149.9K | +64.4% |
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | $4.98M | -1.6% |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $15.00M | +10.0% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $7.57M | -56.4% |
| Biotricity Inc. (BTCY) | 2026-03-31 | $2.76M | +28.2% |
| Profound Medical Corp. (PROF) | 2025-12-31 | $20.60M | +21.4% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $10.24M | -39.2% |
Compare NXGL, WOK, MDNC, NMTC side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗